Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Verapamil recommended for first-line treatment of cluster headache

Oct. 19, 1998

Subtype-selective 5-HT1D agonists developed at MS&D for migraine

Oct. 19, 1998

Lundbeck describes novel class for psychiatric and neurological disorders

Oct. 19, 1998

CIMA completes study of Zomig using OraSolv technology

Oct. 19, 1998

Patent protection for method of treating neurodegenerative disorders pioneered by NeoTherapeutics

Oct. 16, 1998

Ampakine compounds receive further patent protection; update on progress of second-generation drug

Oct. 15, 1998

International research team elucidates role of ubiquitin pathway in Parkinson's disease

Oct. 15, 1998

Chinese herbal extract prevents stress and fatigue in preclinical models

Oct. 15, 1998

Israeli investigators disclose novel series of neuroprotective compounds

Oct. 15, 1998

Sepracor initiates clinical testing with Prozac isomer

Oct. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...